Why EU MDR Compliance Matters for Medical Device Companies

EU MDR compliance is essential for any company that wants to place or keep medical devices on the EU market. MDR compliance affects product design, risk management, clinical evaluation, technical documentation, labeling, supplier control, UDI, EUDAMED registration, vigilance, and post-market surveillance.

A weak MDR compliance process can create serious business risks, including delayed CE marking, incomplete technical files, notified body findings, product launch delays, customer complaints, regulatory scrutiny, or market access problems.

For many companies, the challenge is not a lack of effort. The challenge is that MDR evidence is often scattered across spreadsheets, emails, supplier folders, quality systems, shared drives, and disconnected regulatory trackers. That makes it difficult to answer basic compliance questions quickly, such as:

• Which MDR requirements apply to this device?
• Is the technical documentation complete?
• Are supplier declarations current?
• Is the UDI data aligned with product records?
• Are PMS outputs linked to CAPA, risk management, and technical file updates?
• Are we ready for notified body review?

This is why many medical device companies now look for a structured MDR compliance service or software solution.

Latest EU MDR Updates Companies Need to Know in 2026

1. EUDAMED’s First Four Modules Became Mandatory in May 2026

One of the biggest MDR updates is the mandatory use of EUDAMED. As of 28 May 2026, the first four EUDAMED modules became mandatory: Actor Registration, UDI/Device Registration, Notified Bodies & Certificates, and Market Surveillance.

This update is important because companies must now pay closer attention to the accuracy and consistency of their product data. Device records, UDI information, certificates, actor details, technical documentation, and labeling information should be aligned.

For manufacturers, importers, distributors, and authorized representatives, EUDAMED is no longer only a future preparation task. It is now part of operational MDR compliance.

2. New Notified Body Rules Were Published in 2026

Commission Implementing Regulation (EU) 2026/977 introduced uniform quality management and procedural requirements for notified body conformity assessment activities under the MDR and IVDR.

The regulation aims to make notified body processes more harmonized and predictable. It includes requirements related to quotations, conformity assessment timelines, application reviews, QMS audits, product verification, certificate decisions, change assessments, and re-certification.

The regulation applies from 25 February 2027, while Article 4(4) applies from 1 January 2028.

For medical device companies, this means preparation quality matters more than ever. A complete, structured, and traceable submission package can help reduce delays, questions, and repeated documentation gaps during notified body review.

3. EU MDR and IVDR Simplification Has Been Proposed, But Not Finalized

On 16 December 2025, the European Commission proposed targeted changes to simplify and reduce the burden of the MDR and IVDR rules. The proposal is intended to make the framework easier, faster, and more effective while maintaining patient safety.

However, this is still a proposal. Companies should monitor the development, but they should not delay current MDR compliance work. Existing MDR obligations, EUDAMED requirements, QMS duties, PMS processes, and notified body expectations continue to apply.

4. Electronic Instructions for Use Rules Were Updated

Commission Implementing Regulation (EU) 2025/1234 amended the rules on electronic instructions for use for medical devices.

For companies using or considering electronic IFUs, this means documentation control, user access, website availability, version management, and alignment with UDI/device registration data must be carefully managed.

5. Legacy Device Transition Periods Still Require Active MDR Work

Regulation (EU) 2023/607 amended transitional provisions for certain medical devices and IVDs.

This extension is often misunderstood. It does not mean companies can ignore MDR. Legacy device manufacturers still need to maintain compliance, manage QMS requirements, avoid unapproved significant changes, prepare technical documentation, and progress toward MDR conformity assessment where required.

6. Supply Interruption and Discontinuation Notifications Are Now More Important

Regulation (EU) 2024/1860 amended the MDR and IVDR regarding gradual EUDAMED rollout and the obligation to inform authorities about certain interruptions or discontinuations of supply.

This makes supply chain visibility, product criticality assessment, supplier communication, and internal escalation procedures important parts of MDR compliance planning.

Who Needs an EU MDR Compliance Service?

An EU MDR compliance service is useful for companies that need structured support to understand, implement, prove, and maintain compliance with MDR 2017/745.

This includes:

A company should consider MDR compliance support if it is struggling with incomplete technical files, unclear classification, missing supplier evidence, EUDAMED preparation, PMS documentation gaps, outdated declarations, inconsistent product data, or upcoming notified body review.

What Does EU MDR Compliance Require?

MDR-Ready Quality Management System

The MDR expects manufacturers to maintain a quality management system that supports regulatory compliance throughout the device lifecycle. ComplyMarket’s MDR compliance page highlights QMS, technical documentation, clinical evaluation, PRRC, UDI, PMS, and vigilance as key MDR compliance pillars.

A strong MDR QMS should cover document control, supplier control, risk management, design and development, clinical evaluation, PMS, vigilance, CAPA, internal audits, training, management review, and change control.

Correct Device Classification

Device classification determines the conformity assessment route, notified body involvement, clinical evidence expectations, PMS obligations, technical file depth, and certification timelines.

Companies should document the intended purpose, target population, user profile, claims, accessories, variants, and classification rationale. If the product claim changes, the classification and MDR strategy may also need to be reviewed.

Technical Documentation and GSPR Evidence

MDR technical documentation must show that the device meets the applicable General Safety and Performance Requirements, also known as GSPRs.

A strong technical file should include:

• Device description and specification
• Intended purpose and claims
• Classification rationale
• Risk management documentation
• GSPR checklist
• Verification and validation evidence
• Clinical evaluation documentation
• Labeling and IFU
• UDI information
• PMS plan and PMS outputs
• Supplier and material evidence
• Declaration of conformity
• Change history and version control

The real challenge is not only creating these documents. The challenge is keeping them current and traceable.

Clinical Evaluation and PMCF

Clinical evaluation is a core MDR requirement. Manufacturers must demonstrate that their device is safe and performs as intended based on appropriate clinical evidence.

Where applicable, post-market clinical follow-up should be planned, documented, and connected to PMS, risk management, benefit-risk conclusions, and technical documentation updates.

UDI and EUDAMED Readiness

UDI and EUDAMED are now practical compliance priorities. Since the first four EUDAMED modules became mandatory on 28 May 2026, companies need accurate device master data, Basic UDI-DI, UDI-DI, certificates, actor records, and registration workflows.

A common problem is inconsistency between labels, IFUs, technical documentation, declarations, ERP data, and EUDAMED entries. Companies need a controlled process to keep product data aligned.

Post-Market Surveillance, Vigilance, CAPA, and PSUR

MDR compliance continues after market placement. Manufacturers must collect and evaluate post-market data, review complaints, detect trends, manage incidents, update risk files, and implement corrective actions when needed.

A strong PMS system should connect:

• Complaints
• Incidents
• Trend reports
• PMS reports or PSURs
• CAPA
• Risk management updates
• Clinical evaluation updates
• Technical documentation changes
• Supplier or component issues

This helps companies show that post-market data is actively used to maintain product safety and performance.

Supplier and Material Compliance

Medical device manufacturers often rely on suppliers for components, materials, coatings, substances, packaging, sterilization processes, and test evidence. Weak supplier documentation can create MDR technical file gaps.

Supplier evidence may include declarations, specifications, material data, test reports, change notifications, certificates, substance information, and manufacturing process data.

This is especially important for Annex I substance-related obligations, labeling decisions, risk management, and technical documentation evidence.

What Happens If a Company Is Not MDR Compliant?

MDR non-compliance can create both regulatory and commercial consequences. Depending on the issue, companies may face:

• Delayed CE marking
• Failed or prolonged notified body review
• Technical documentation findings
• Product launch delays
• Market access problems
• Customer or distributor concerns
• Increased audit pressure
• Corrective and preventive actions
• Product withdrawal or other market surveillance actions in serious cases

For many companies, the biggest cost is delay. A missing document, expired supplier certificate, inconsistent UDI record, or weak PMS connection can slow down certification, block market entry, or create avoidable rework.

That is why MDR compliance should be managed as a continuous system, not as a one-time documentation project.

Why Spreadsheets Are Not Enough for MDR Compliance

Spreadsheets may work in the early stages, but they become risky when a company has multiple devices, suppliers, materials, certificates, markets, and regulatory obligations.

The main problems with spreadsheet-based MDR management are:

• No reliable version control
• Limited traceability between requirements and evidence
• Manual tracking of expired documents
• Difficult supplier follow-up
• Hard-to-prove audit trail
• Poor visibility across product families
• High risk of duplicate or outdated information
• Slow preparation for notified body questions
• Weak connection between PMS, CAPA, risk, and technical files

MDR compliance requires structured, searchable, and audit-ready evidence. A software-based system helps companies move from fragmented document collection to controlled compliance management.

EU MDR Compliance Checklist for Medical Device Companies

Use this checklist to assess whether your MDR compliance process is ready.

How ComplyMarket Product Compliance Software Helps with MDR Requirements

ComplyMarket helps companies make product compliance more structured, traceable, and scalable. Its product compliance management software is designed to give manufacturers, importers, and product managers a centralized platform for managing regulatory obligations.

For companies managing EU MDR compliance, ComplyMarket can help in the following ways.

1. Centralize MDR Requirements and Product Evidence

ComplyMarket allows companies to manage regulatory obligations, product data, components, materials, substances, and compliance evidence in a structured way. Its software helps teams move away from spreadsheets and disconnected data by keeping compliance information searchable and organized.

For MDR teams, this can support technical documentation, GSPR evidence mapping, product family management, supplier evidence tracking, and audit preparation.

2. Manage Technical Documentation More Efficiently

MDR technical documentation must stay complete, current, and linked to the right product version. ComplyMarket’s technical compliance approach focuses on identifying technical rules, collecting required evidence, maintaining technical documentation, and deciding whether a product is ready for the market.

This helps companies answer important MDR questions faster, such as which evidence supports a requirement, which documents are missing, and whether a device is ready for review.

3. Track Supplier Evidence and Material Data

Supplier documentation is one of the most common MDR pain points. ComplyMarket supports collaboration with teams and suppliers, including assigning tasks and requesting documentation within the same platform.

This can help medical device companies collect and manage supplier declarations, certificates, material specifications, substance data, and other evidence needed for MDR technical files.

4. Improve UDI and EUDAMED Data Readiness

Because EUDAMED’s first four modules became mandatory on 28 May 2026, companies need better control over device master data, certificates, UDI records, and actor information.

ComplyMarket can help by supporting structured product compliance records and evidence control, reducing the risk of inconsistencies between internal documentation and external registration requirements.

5. Use Alerts for Missing or Expiring Evidence

ComplyMarket enables companies to determine and track the evidence required for each regulatory obligation and receive automated alerts when evidence is missing or due to expire.

For MDR compliance, this is especially useful for supplier certificates, declarations, test reports, PMS deadlines, notified body preparation, document renewals, and technical file maintenance.

6. Support PMS, CAPA, and Change Control Traceability

MDR requires continuous compliance. A post-market issue may affect risk management, clinical evaluation, supplier controls, labeling, technical documentation, or CAPA.

ComplyMarket can help teams manage compliance evidence across products, components, materials, and substances, which is important because medical device evidence often exists at multiple levels of the product structure.

7. Make Compliance More Audit-Ready

A strong MDR compliance system should allow teams to quickly answer:

• Which MDR obligations apply to this device?
• Which evidence proves compliance?
• Which supplier documents are missing?
• Which certificates are expiring?
• Which product versions are affected by a change?
• Is the technical file ready for review?
• Is the device marketable in the target country?

ComplyMarket’s product compliance software supports regulatory libraries, evidence management, early warnings, supplier collaboration, and marketability checks.

Why Choose ComplyMarket for EU MDR Compliance Support?

ComplyMarket is especially useful for companies that want to replace fragmented MDR workflows with a centralized product compliance platform.

Instead of managing MDR compliance through separate spreadsheets, email chains, shared folders, and manual reminders, ComplyMarket helps teams organize regulatory requirements, product data, supplier evidence, technical documentation, compliance tasks, and alerts in one place.

This is valuable for:

• Manufacturers preparing MDR technical documentation
• Importers and distributors checking product compliance evidence
• QA/RA teams preparing for notified body review
• Product compliance teams managing components, materials, and substances
• Companies preparing for EUDAMED and UDI obligations
• Businesses that need stronger supplier documentation control
• Teams that want to reduce manual follow-up and compliance risk

The result is a more structured, transparent, and audit-ready MDR compliance process.

Frequently Asked Questions About EU MDR Compliance

What is EU MDR compliance?

EU MDR compliance means meeting the requirements of Regulation (EU) 2017/745 for medical devices placed on the EU market. This includes classification, QMS, technical documentation, clinical evaluation, risk management, UDI, EUDAMED, PMS, vigilance, and supplier control.

Who must comply with the EU MDR?

Manufacturers, authorized representatives, importers, and distributors all have MDR responsibilities. ComplyMarket’s MDR compliance page notes that MDR assigns obligations across the supply chain, including verification, recordkeeping, complaint handling, and cooperation duties.

Is EUDAMED mandatory now?

Yes, the first four EUDAMED modules became mandatory from 28 May 2026: Actor Registration, UDI/Device Registration, Notified Bodies & Certificates, and Market Surveillance.

Do legacy devices still need MDR compliance work?

Yes. Transitional provisions may give eligible legacy devices more time, but companies still need to manage MDR conditions, QMS requirements, technical documentation, notified body planning, and ongoing compliance duties. Regulation (EU) 2023/607 amended transition rules for certain devices.

Can software help with MDR compliance?

Yes. MDR compliance involves large amounts of evidence, supplier data, technical documentation, deadlines, product records, UDI information, and post-market data. Product compliance software can help centralize this information, track missing or expiring evidence, support supplier collaboration, and improve audit readiness.